Selenoprotein deficiency disorder predisposes to aortic aneurysm formation.
Erik SchoenmakersFederica MarelliHelle F JørgensenW. Edward VisserCarla MoranStefan GroenewegCarolina AvalosSean Joseph JurgensNichola FiggAlison FiniganNeha WaliMaura AgostiniHannah Wardle-JonesGreta LyonsRosemary RuskDeepa GopalanPhilip TwissJacob J VisserMartin GoddardSamer A M NashefRobin HeijmenPaul CliftSanjay SinhaJames Paul PirruccelloPatrick T EllinorElisabeth M Busch-NentwichRamiro Ramirez-SolisMichael P MurphyLuca PersaniMartin R BennettKrishna ChatterjeePublished in: Nature communications (2023)
Aortic aneurysms, which may dissect or rupture acutely and be lethal, can be a part of multisystem disorders that have a heritable basis. We report four patients with deficiency of selenocysteine-containing proteins due to selenocysteine Insertion Sequence Binding Protein 2 (SECISBP2) mutations who show early-onset, progressive, aneurysmal dilatation of the ascending aorta due to cystic medial necrosis. Zebrafish and male mice with global or vascular smooth muscle cell (VSMC)-targeted disruption of Secisbp2 respectively show similar aortopathy. Aortas from patients and animal models exhibit raised cellular reactive oxygen species, oxidative DNA damage and VSMC apoptosis. Antioxidant exposure or chelation of iron prevents oxidative damage in patient's cells and aortopathy in the zebrafish model. Our observations suggest a key role for oxidative stress and cell death, including via ferroptosis, in mediating aortic degeneration.
Keyphrases
- aortic valve
- oxidative stress
- cell death
- cell cycle arrest
- early onset
- dna damage
- induced apoptosis
- smooth muscle
- pulmonary artery
- end stage renal disease
- reactive oxygen species
- aortic aneurysm
- late onset
- binding protein
- aortic dissection
- chronic kidney disease
- endoplasmic reticulum stress
- diabetic rats
- ejection fraction
- pi k akt
- coronary artery
- multiple sclerosis
- ischemia reperfusion injury
- left ventricular
- peritoneal dialysis
- stem cells
- single cell
- pulmonary hypertension
- dna repair
- patient reported outcomes
- cancer therapy
- cell therapy
- drug delivery
- heat shock
- amino acid